Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

loneliness

Theresa May launches UK’s first loneliness strategy

The prime minister has announced that all GPs in England will be able to refer patients suffering from loneliness to community activities by 2023.
challenge of dementia

A balanced approach to the global challenge of dementia

Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia
prevent Alzheimer's disease

Working to treat and prevent Alzheimer’s disease and related dementias

Dr Richard Hodes, Director of the National Institute on Aging within the U.S. National Institutes of Health, explores the importance of working together to treat and prevent Alzheimer’s disease and related dementias.
hearing loss

Addressing hearing loss could reduce the risk of Dementia

In recognition of World Alzheimer’s Day, hearing aid provider, Oticon, explains why successfully addressing hearing loss could reduce the risk of early on-set dementia
Alzheimer’s disease

Infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease

Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
dementia research

Why more investment is needed to put people at the heart of dementia research

Colin Capper, Head of Research Development and Evaluation at Alzheimer’s Society, discusses why greater investment is needed in today’s dementia care research
dementia research

Greater research investment is needed for a dementia breakthrough

Dr Doug Brown, Chief Policy and Research Officer at Alzheimer’s Society, discusses why more investment is needed in dementia research
dementia friendly

People with dementia in rural communities increasingly isolated, says Alzheimer’s Society

Charity launches guide urging individuals and organisations in rural communities to take action to become more dementia friendly, for Dementia Action Week (21-27 May)
brain disease test

National Institutes of Health scientists adapt new brain disease test for Parkinson’s

National Institutes of Health scientists develop new brain disease test for the early diagnosis of Parkinson’s disease and dementia with Lewy bodies The group, led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), tested 60 cerebral spinal fluid samples, including 12 from people with Parkinson’s disease, 17 from...
air pollution on the brain

An emerging environmental health concern: Impacts of air pollution on the brain

Anthony S. Wexler and Pamela J. Lein from the University of California share their expert views on the impacts of air pollution on the brain Air pollution is a complex mixture of gases and particles in the atmosphere. Air pollutants are defined as compounds known to be deleterious to human...
drug development for neurodegenerative diseases concept

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...

PET imaging of neurodegenerative diseases

Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging
progressive condition

Dementia as a progressive condition

The Alzheimer's Society in the UK provides a fascinating glimpse into the most dementia as a progressive condition and its common forms

Can a new light-based therapy help with Alzheimer’s disease?

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Finding effective treatments for vascular dementia

Dr Doug Brown, Director of Research, Alzheimer’s Society provides details on the research into vascular dementia and explains why more work is needed Vascular dementia is the second most common type of dementia, accounting for almost one fifth of all cases. By 2025, it is estimated there will be 250,000...

Tackling cognitive decline in Alzheimer’s disease

Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition Alzheimer’s disease (AD) represents the most common cause of dementia, accounting for 60% to 80% of all dementia cases. There are currently only a few interventions that...

Pharmacogenomics of polypharmacy in Alzheimer’s disease

Ramón Cacabelos of EuroEspes Biomedical Research Center details how the incorporation of pharmacogenomics to treat Alzheimer’s patients is crucial
Dementia research: Translating knowledge into new treatments

Dementia research: Translating knowledge into new treatments

Chief Executive Hilary Evans highlights how Alzheimer’s Research UK is helping advance dementia research, but warns there is still more to be done
Italy's ageing population ladies walking Florence

Italy’s ageing population and the healthcare challenge

Open Access Government examines some of the statistics around Italy's ageing population, related health challenges, and policy action to address the issue Italy is currently the country with the second highest number of older people – behind Germany. In 2013, it was estimated that more than 12 million elderly people...
Old and young woman make personal budgets dementia friendly

Making personal budgets dementia friendly

A sea change is needed among local authorities to make personal budgets dementia friendly, argues George McNamara of the Alzheimer’s Society People with dementia and their families tell us of the very real impact personal budgets have had on their lives – from the 85 year old woman who returned...

Latest Articles